185 related articles for article (PubMed ID: 32922001)
1. Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications.
Rondon EP; Benabdoun HA; Vallières F; Segalla Petrônio M; Tiera MJ; Benderdour M; Fernandes JC
Int J Nanomedicine; 2020; 15():6183-6200. PubMed ID: 32922001
[TBL] [Abstract][Full Text] [Related]
2. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
3. In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.
Shi Q; Rondon-Cavanzo EP; Dalla Picola IP; Tiera MJ; Zhang X; Dai K; Benabdoune HA; Benderdour M; Fernandes JC
Int J Nanomedicine; 2018; 13():387-402. PubMed ID: 29391796
[TBL] [Abstract][Full Text] [Related]
4. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA.
Malhotra M; Tomaro-Duchesneau C; Saha S; Kahouli I; Prakash S
Int J Nanomedicine; 2013; 8():2041-52. PubMed ID: 23723699
[TBL] [Abstract][Full Text] [Related]
6. Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.
de Souza RHFV; Picola IPD; Shi Q; Petrônio MS; Benderdour M; Fernandes JC; Lima AMF; Martins GO; Martinez Junior AM; de Oliveira Tiera VA; Tiera MJ
Int J Biol Macromol; 2018 Nov; 119():186-197. PubMed ID: 30031084
[TBL] [Abstract][Full Text] [Related]
7. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoparticles for siRNA delivery: optimizing formulation to increase stability and efficiency.
Ragelle H; Riva R; Vandermeulen G; Naeye B; Pourcelle V; Le Duff CS; D'Haese C; Nysten B; Braeckmans K; De Smedt SC; Jérôme C; Préat V
J Control Release; 2014 Feb; 176():54-63. PubMed ID: 24389132
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of Fe
Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles.
Rudzinski WE; Palacios A; Ahmed A; Lane MA; Aminabhavi TM
Carbohydr Polym; 2016 Aug; 147():323-332. PubMed ID: 27178938
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
14. A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis.
Malhotra M; Lane C; Tomaro-Duchesneau C; Saha S; Prakash S
Int J Nanomedicine; 2011; 6():485-94. PubMed ID: 21562608
[TBL] [Abstract][Full Text] [Related]
15. Graphene oxide functionalized with chitosan based nanoparticles as a carrier of siRNA in regulating Bcl-2 expression on Saos-2 & MG-63 cancer cells and its inflammatory response on bone marrow derived cells from mice.
Saravanabhavan SS; Rethinasabapathy M; Zsolt S; Kalambettu AB; Elumalai S; Janakiraman M; Huh YS; Natesan B
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1459-1468. PubMed ID: 30889680
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Wang F; Wang Y; Ma Q; Cao Y; Yu B
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
[TBL] [Abstract][Full Text] [Related]
17. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
18. Divalent folate modification on PEG: an effective strategy for improving the cellular uptake and targetability of PEGylated polyamidoamine-polyethylenimine copolymer.
Cao D; Tian S; Huang H; Chen J; Pan S
Mol Pharm; 2015 Jan; 12(1):240-52. PubMed ID: 25514347
[TBL] [Abstract][Full Text] [Related]
19. Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.
Corbet C; Ragelle H; Pourcelle V; Vanvarenberg K; Marchand-Brynaert J; Préat V; Feron O
J Control Release; 2016 Feb; 223():53-63. PubMed ID: 26699426
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro characterization of PEGylated chitosan and polyethylene imine polymers with thrombospondin-I gene bearing pDNA.
Saka OM; Bozkir A
J Biomed Mater Res B Appl Biomater; 2012 May; 100(4):984-92. PubMed ID: 22279036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
